Sio Capital Management, LLC Moleculin Biotech, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.72 $12,220 - $23,154	-32,159 Reduced 10.6%	271,230 $116,000
Q2 2023 Aug 14, 2023	SELL	$0.54 - $0.95 $382,086 - $672,188	-707,567 Reduced 69.99%	303,389 $175,000
Q1 2023 May 12, 2023	SELL	$0.9 - $1.34 $23,307 - $34,701	-25,897 Reduced 2.5%	1,010,956 $970,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $2.0 $4,374 - $7,352	-3,676 Reduced 0.35%	1,036,853 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$2.7 - $3.59 $96,346 - $128,105	35,684 Added 3.55%	1,040,529 $3.12 Million
Q2 2021 Aug 16, 2021	BUY	$3.21 - $4.06 $134,322 - $169,890	41,845 Added 4.35%	1,004,845 $3.69 Million
Q1 2021 May 14, 2021	BUY	$3.7 - $6.42 $3.56 Million - $6.18 Million	963,000 New	963,000 $3.93 Million

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $48.6M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.